MET and mucosal melanoma: One-hundred melanocytic lesions were evaluated for expression of MET and PD-L1 in a human tissue microarray (TMA) with benign nevi (17 patients), primary cutaneous melanomas (42 patients), primary mucosal melanomas (20 patients), and metastatic melanomas (21 patients).